A score system for complete cytoreduction in selected recurrent ovarian cancer patients undergoing secondary cytoreductive surgery: predictors- and nomogram-based analyses.
Giorgio BoganiElena TagliabueMauro SignorelliAntonino DittoFabio MartinelliValentina ChiappaLavinia MoscaIlaria SabatucciUmberto Leone Roberti MaggioreDomenica LorussoFrancesco RaspagliesiPublished in: Journal of gynecologic oncology (2018)
The AGO and MSK criteria help identifying patients deserving SCS. However, these criteria might be strict, thus prohibiting a beneficial treatment in patients who do not met these criteria. Further studies are needed to clarify factors predicting CC at SCS.